https://doi.org/10.1186/s12888-017-1358-3
E
Erik Muser
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
1.0K
Citations
20
h-index
35
i10-index
Erik Muser is an academic researcher from Johnson & Johnson (United States). The author has contributed to research in topics: Inflammatory Bowel Disease & Health Systems, Economic Evaluations, Quality of Life & Schizophrenia research and treatment. The author has an h-index of 20, co-authored 110 publications.
Papers by this author
worksAdherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophrenia
2017 · BMC Psychiatry · 40 citations
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
2015 · Drugs - Real World Outcomes · 28 citations
https://doi.org/10.1007/s40801-015-0043-4
Real-World Persistence, Maintenance Dosing, and Pre-Post Corticosteroid and Opioid Use Among Crohn’s Disease Patients with Prescription Claims for Ustekinumab in the USA
2021 · Drugs - Real World Outcomes · 13 citations
https://doi.org/10.1007/s40801-021-00264-5
The economic burden of psoriasis with high comorbidity among privately insured patients in the United States
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7435874
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat